Does the Ingestion of Mycoprotein Elicit an Optimal Anabolic Response in Resting and Exercised Skeletal Muscle?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-26

Study Completion Date

2022-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study will seek to quantify the muscle protein synthetic response to mycoprotein feeding, comparing it to milk protein as a gold standard and heavily researched positive control

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mycoprotein and Muscle Protein Synthetic Response

NCT04084652

Anabolic Response to Mycoprotein and Micronutrient Ingeston

COMPLETED NA

The Impact of Enteral Versus Oral Protein Feeding on Muscle Protein Synthesis in Healthy Young Males and Females

NCT03571425

Healthy

COMPLETED NA

Mycoprotein and Pea Protein Blend and Muscle Protein Synthetic Response

NCT04894747

Muscle Protein Synthesis

COMPLETED NA

The Muscle Protein Synthetic Response of Algal and Fungal Protein

NCT05016557

Muscle Metabolism

COMPLETED NA

Mycoprotein, Resistance Training, and Hypertrophy

NCT03572127

Hypertrophy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mycoprotein beverage

Group Type ACTIVE_COMPARATOR

Mycoprotein beverage

Intervention Type OTHER

Mycoprotein protein beverage

Milk protein beverage

Group Type PLACEBO_COMPARATOR

Milk protein beverage

Intervention Type OTHER

Milk protein beverage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mycoprotein beverage

Mycoprotein protein beverage

Intervention Type OTHER

Milk protein beverage

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• BMI between 18 and 30 -

Exclusion Criteria

* Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
* Any diagnosed cardiovascular disease or hypertension.
* Elevated blood pressure at the time of screening (e.g. blood pressure of ≥140/90mmHg).
* Chronic use of any prescribed or over the counter pharmaceuticals.
* A personal or family history of epilepsy, seizures or schizophrenia.
* Anyone with previous motor disorders.
* An allergy to mycoprotein / Quorn, penicillin, or milk.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes